FDA Announces Public Meeting of Cardiovascular and Renal Drugs Advisory Committee

Summary

The Food and Drug Administration (FDA) is hosting a public meeting of its Cardiovascular and Renal Drugs Advisory Committee on March 19, 2009, at the Marriott Conference Centers, UMUC Inn and Conference Center by Marriott, where the committee will provide advice and recommendations on FDA's regulatory issues.